Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) For research use only.
Not for use in humans.

Dapirolizumab (Anti-TNFSF5 / CD40L / CD154)

Synonyms:

Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized immunoglobulin monoclonal antibody that targets TNFSF5. MW : 150 kDa.

Dapirolizumab (Anti-TNFSF5 / CD40L / CD154)

Purity & Quality Control

Batch: A231301 Purity: 99% Protein concentration: 9.33mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective CD markers Inhibitors

Biological Activity

Description Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized immunoglobulin monoclonal antibody that targets TNFSF5. MW : 150 kDa.

Product Details

Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) | Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) supplier | purchase Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) | Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) cost | Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) manufacturer | order Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) | Dapirolizumab (Anti-TNFSF5 / CD40L / CD154) distributor